-
Data show that MABp1 has led to rapid improvement in skin lesions and acne-associated psychological symptoms.
-
Findings are published in the June 2015 issue of Journal of Drugs in Dermatology. (J Drugs Dermatol. June 2015;14(6):560-564)
Posted by Laura Swartz
June 15, 2015 at 11:36 AM
Data show that MABp1 has led to rapid improvement in skin lesions and acne-associated psychological symptoms.
Findings are published in the June 2015 issue of Journal of Drugs in Dermatology. (J Drugs Dermatol. June 2015;14(6):560-564)
Posted by Laura Swartz
May 27, 2015 at 2:10 PM
Crystal Research Associates has released a new Executive Informational Overview (EIO) on XBiotech Inc. (XBIT-NASDAQ), a company engaged in discovering, developing, and translating natural human immunity into novel therapeutic antibody products. The 60-page EIO, which details XBiotech's business, technology and product development, manufacturing expertise, market opportunities, competition, and more, is available for download below.
Topics: xbit
We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.
CONTACT INFORMATION
Phone: (212) 851-6685